We also assessed miR-206 in the chronic DUX4-expressing FSHD-like mouse models, as this was a promising candidate biomarker from our analysis using the DUX4-induced ACTA1-MCM;FLExD/+ models. This evidence concerns the gene DUX4 and facioscapulohumeral muscular dystrophy.